Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idarubicin-loaded Beads for Hepatocellular Carcinoma
NCT02185768Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jan 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idarubicin in hepatocellular carcinoma (HCC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Jan 2015; status: completed.
02
Drugs
idarubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02185768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02185768.